Evaluation of clinical efficacy of Chinese medicine in promoting nucleic acid negative transformation of novel coronavirusDelta mutant strain

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
INTERVENTION: Experimental group:Basic treatment + Fuzheng detoxification granules;Control group:Basic treatment; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: The change of viral load; SECONDARY OUTCOME: Nucleic acid negative time; 7‐day/14‐day nucleic acid conversion ratio;The ratio of main symptoms disappeared in 7 days/14 days; 7 days/14 days chest CT imaging changes;Hospital stays;prognosis;Whether there is a retest positive after the nucleic acid turns negative within 21 days; INCLUSION CRITERIA: (1) Meets the diagnostic criteria for COVID‐19 (National Edition 8); (2) Over 18 years old; (3) Normal temperature within 48 hours; (4) With air intake, SpO2>93%; (5) Onset time >=7 days; (6) Signed informed consent.
Epistemonikos ID: 0cdb7c114356780f122c9b199f5dbd1e1660ec0b
First added on: Aug 12, 2021